| Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study C Rungoe, S Basit, MF Ranthe, J Wohlfahrt, E Langholz, T Jess Gut 62 (5), 689-694, 2013 | 205 | 2013 |
| Familial aggregation of lone atrial fibrillation in young persons N Øyen, MF Ranthe, L Carstensen, HA Boyd, MS Olesen, SP Olesen, ... Journal of the American College of Cardiology 60 (10), 917-921, 2012 | 158 | 2012 |
| Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ... Jama 315 (10), 1026-1033, 2016 | 144 | 2016 |
| Pregnancy loss and later risk of atherosclerotic disease MF Ranthe, EAW Andersen, J Wohlfahrt, H Bundgaard, M Melbye, ... Circulation 127 (17), 1775-1782, 2013 | 114 | 2013 |
| Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation G Ahlberg, L Refsgaard, PR Lundegaard, L Andreasen, MF Ranthe, ... Nature communications 9 (1), 4316, 2018 | 103 | 2018 |
| Risk of cardiovascular disease in family members of young sudden cardiac death victims MF Ranthe, BG Winkel, EW Andersen, B Risgaard, J Wohlfahrt, ... European heart journal 34 (7), 503-511, 2013 | 92 | 2013 |
| Family history of premature death and risk of early onset cardiovascular disease MF Ranthe, L Carstensen, N Øyen, J Tfelt-Hansen, M Christiansen, ... Journal of the American College of Cardiology 60 (9), 814-821, 2012 | 76 | 2012 |
| Cardiac involvement in myotonic dystrophy: a nationwide cohort study M Lund, LJ Diaz, MF Ranthe, H Petri, M Duno, I Juncker, H Eiberg, ... European heart journal 35 (32), 2158-2164, 2014 | 68 | 2014 |
| Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ... PloS one 14 (2), e0211857, 2019 | 52 | 2019 |
| A detailed family history of myocardial infarction and risk of myocardial infarction–a nationwide cohort study MF Ranthe, JA Petersen, H Bundgaard, J Wohlfahrt, M Melbye, HA Boyd PLoS One 10 (5), e0125896, 2015 | 49 | 2015 |
| Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese … H Watada, S Kaneko, M Komatsu, BR Agner, T Nishida, M Ranthe, ... Diabetes, Obesity and Metabolism 21 (12), 2694-2703, 2019 | 28 | 2019 |
| Risk of cardiomyopathy in younger persons with a family history of death from cardiomyopathy: a nationwide family study in a cohort of 3.9 million persons MF Ranthe, L Carstensen, N Øyen, MK Jensen, A Axelsson, J Wohlfahrt, ... Circulation 132 (11), 1013-1019, 2015 | 26 | 2015 |
| Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese … K Kaku, E Araki, Y Tanizawa, B Ross Agner, T Nishida, M Ranthe, ... Diabetes, Obesity and Metabolism 21 (12), 2674-2683, 2019 | 22 | 2019 |
| Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based … B Pasternak, H Svanström, MF Ranthe, M Melbye, A Hviid CNS drugs 28, 963-973, 2014 | 22 | 2014 |
| Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study MF Ranthe, LJ Diaz, I Behrens, H Bundgaard, J Simonsen, M Melbye, ... European Heart Journal 37 (11), 900-907, 2016 | 17 | 2016 |
| Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial I Lingvay, S Harris, E Jaeckel, K Chandarana, MF Ranthe, E Jódar Diabetes, Obesity and Metabolism 20 (1), 200-205, 2018 | 16 | 2018 |
| IDegLira improves glycemic control in Japanese patients with uncontrolled type 2 diabetes on premixed insulin therapy H Watada, BF Ross Agner, A Doshi, L Bardtrum, MF Ranthe, LK Billings Diabetes Therapy 11, 331-339, 2020 | 15 | 2020 |
| Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: a DEVOTE subanalysis (DEVOTE 10) K Brown‐Frandsen, SS Emerson, DK McGuire, TR Pieber, NR Poulter, ... Diabetes, Obesity and Metabolism 21 (6), 1437-1444, 2019 | 15 | 2019 |
| Persistence with IDegLira in patients in clinical practice: a nationwide observational study in Sweden B Eliasson, J Ekelund, M Miftaraj, MF Ranthe, AC Mårdby, ... Diabetes Therapy 11, 1807-1820, 2020 | 10 | 2020 |
| Insulin degludec/liraglutide (ID egLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that … L Meneghini, A Doshi, D Gouet, T Vilsbøll, K Begtrup, P Őrsy, MF Ranthe, ... Diabetic Medicine 37 (2), 267-276, 2020 | 9 | 2020 |
